 |
 |
   |
Sirolimus
|
Sirolimus is a highly potent, broad-acting mTOR inhibitor that has demonstrated the ability to combat disease through a broad spectrum of therapeutic action including the inhibition of inflammation, angiogenesis, vascular permeability, proliferation and fibrosis. The inherent versatility associated with these activities, combined with the compound's proven safety profile, positions sirolimus as a potentially highly efficacious therapeutic for a wide range of ocular diseases and conditions. |
   |